Drug‐induced liver injury as assessed by the updated Roussel Uclaf Causality Assessment Method following mild COVID‐19 in a patient under anastrozole therapy—A case report

Documenti analoghi

• Prediction for oxaliplatin‐induced liver injury using patient‐derived liver organoids
  di: Kumiko Tatsumi, et al.
  Pubblicazione: (2024)
• Liver Injury in People With HIV on Antituberculosis and/or Antiretroviral Therapy—Assessing Causality Using the Updated Roussel Uclaf Causality Assessment Method
  di: H. M. Gunter, et al.
  Pubblicazione: (2024)
• Joint guideline update recommendations for postmastectomy radiation therapy
  di: Leah Lawrence
  Pubblicazione: (2026)
• Liver‐directed therapies for colorectal liver metastases
  di: Andrew D. Folkerts, et al.
  Pubblicazione: (2025)
• Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR‐mutated lung cancer and pulmonary tuberculosis: A case report
  di: Hiroaki Matsuura, et al.
  Pubblicazione: (2024)